Common Pathogenic Mechanisms between Down Syndrome and Alzheimer's Disease: Steps toward Therapy

Book Series: Recent Advances in Alzheimer Research

Volume 1


Ahmad Salehi, Michael Rafii, Cristy Phillips

DOI: 10.2174/97816810813801150101
eISBN: 978-1-68108-138-0, 2015
ISBN: 978-1-68108-139-7
ISSN: 2452-2554 (Print)
ISSN: 2452-2562 (Online)

Indexed in: Scopus, EBSCO.

Down syndrome is a chromosomal disorder affecting more than 5.8 million individuals worldwide. Down syndrome can be viewed as a comple...[view complete introduction]
US $
Buy Personal eBook
Order Library eBook
Order Printed Copy
Order PDF + Printed Copy (Special Offer)

*(Excluding Mailing and Handling)

🔒Secure Checkout Personal information is secured with SSL technology

Sleep Abnormalities in Down Syndrome and Alzheimer’s Disease: Cognitive Consequences and New Therapeutic Strategies

- Pp. 90-115 (26)

Damien Colas


Historically, sleep has been seen as a passive state, and yet more recent research demonstrates that sleep is a time for the brain and body to actively fulfill functions pertaining to cognition, metabolism, and cellular maintenance. Clinical studies of sleep using polysomnography have demonstrated profound sleep disturbances in Down syndrome and Alzheimer disease. Deriving from these basic studies is a better understanding of the networks, neurotransmitters systems, and physiological and genetic factors that regulate the daily organization of sleep and wake cycles. Currently, physiological and pharmacological means for manipulating sleep are being developed. Therefore, it seems plausible that sleep and EEG studies may soon be used to develop new biomarkers for Down syndrome and Alzheimer’s disease and, in turn, improve quality of life.

Purchase Chapter  Book Details


Webmaster Contact: Copyright © 2019 Bentham Science